Ticker Symbol: KDMN
Kadmon Holdings Inc
$9.50 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001557142
Company Profile
Kadmon is a clinical-stage biopharmaceutical company that discovers, develops and delivers transformative therapies for unmet medical needs. Its clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 450 E 29th St
Website: kadmon.com
CEO: N/A
Tags:
- Health Technology
- Biotechnology
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change:
$0.02
(
0.21%)
Days Range: $9.48 - $9.50
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change 0.21%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 178521071
Valuation
Market Cap: 169.6B
PE Ratio: -13.43
EPS (TTM): -0.7072
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A